The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease;Wpływ chorób współistniejących na długość leczenia szpitalnego u chorych z zaostrzeniem przewłeklej obturacyjnej choroby płuc

Pneumonologia i Alergologia Polska

Volumn 79, Issue 6, 2011, Pages 388-396

  Nowiński, Adam ^a   Kamiński, Dariusz ^a   Korzybski, Damian ^a   Stokłosa, Anna ^a   Górecka, Dorota ^a  

^a INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

Author keywords

Comorbidities; COPD; COPD exacerbation; Hospital treatment length

Indexed keywords

EID: 80055115272     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2008). Bethesda: National Heart, Lung and Blood Institute, 2008. www.goldcopd.org
2. Batura-Gabryel H. Zmiany ogólnoustrojowe u chorych na przewlekła{ogonek} obturacyjna{ogonek} chorobe{ogonek} płuc. Pneumonol. Alergol. Pol. 2009; 77: 180-185.
3. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009; 33: 1165-1185.
4. Pierzchała W., Barczyk A., Górecka D., Śliwiński P., Zieliński J. Zalecenia Polskiego Towarzystwa Chorób Płuc rozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc (POChP). Pneumonol. Alergol. Pol. 2010; 78: 318-347.
5. Nielsen R., Johannessen A., Omenaas E.R., Bakke P.S., Askildsen J.E., Gulsvik A. Excessive costs of COPD in ever-smokers. A longitudinal community study. Respir. Med. 2011; 105: 485-493.
6. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 1987; 40: 373-383.
7. Mapel D.W., Hurley J.S., Frost F.J., Petersen H.V., Picchi M.A., Coultas D.B. Health care utilization in chronic obstructive pul monary disease. A case-control study in a health maintenance organization. Arch. Intern. Med. 2000; 160: 2653-2658.
8. Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
9. Donaldson G.C., Hurst J.R., Smith C.J., Hubbard R.B., Wedzicha J.A. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010; 137: 1091-1097.
10. Similowski T., Agusti A., MacNee W., Schönhofer B. The potential impact of anaemia of chronic disease in COPD. Eur. Respir. J. 2006; 27: 390-396.
11. Vestbo J., Prescott E., Almdal T. i wsp. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am. J. Respir. Crit. Care Med. 2006; 173: 79-83.
12. Incalzi R.A., Corsonello A., Pedone C., Battaglia S., Paglino G., Bellia V. Extrapulmonary Consequences of COPD in the Elderly Study Investigators. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137: 831-837.
13. Celli B.R., Cote C.G., Marin J.M. i wsp. The body-mass index, airflow obstruction, dyspnea, and eExercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005-1012.